Abstract
Dopamine action alters gene regulation in striatal neurons. Methylphenidate increases extracellular levels of dopamine. We investigated the effects of acute methylphenidate treatment on gene expression in the striatum of adult rats. Molecular changes were mapped in 23 striatal sectors mostly defined by their predominant cortical inputs in order to determine the functional domains affected. Acute administration of 5 and 10 mg/kg (i.p.) of methylphenidate produced robust increases in the expression of the transcription factor c-fos and the neuropeptide substance P. Borderline effects were found with 2 mg/kg, but not with 0.5 mg/kg. For 5 mg/kg, c-fos mRNA levels peaked at 40 min and returned to baseline by 3 h after injection, while substance P mRNA levels peaked at 40–60 min and were back near control levels by 24 h. These molecular changes occurred in most sectors of the caudate-putamen, but were maximal in dorsal sectors that receive sensorimotor and medial agranular cortical inputs, on middle to caudal levels. In rostral and ventral striatal sectors, changes in c-fos and substance P expression were weaker or absent. No effects were seen in the nucleus accumbens, with the exception of c-fos induction in the lateral part of the shell. In contrast to c-fos and substance P, acute methylphenidate treatment had minimal effects on the opioid peptides dynorphin and enkephalin. These results demonstrate that acute methylphenidate alters the expression of c-fos and substance P preferentially in the sensorimotor striatum. These molecular changes are similar, but not identical, to those produced by other psychostimulants.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Acheson AW, Thompson AC, Kristal MB, Baizer JS (2001). Methylphenidate induces c-fos expression in juvenile rats. Soc Neurosci Abstr 27: 223.4.
Adams DH, Hanson GR, Keefe KA (2001). Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum. Neuroscience 102: 843–851.
Adams DH, Hanson GR, Keefe KA (2003). Distinct effects of methamphetamine and cocaine on preprodynorphin messenger RNA in rat striatal patch and matrix. J Neurochem 84: 87–93.
Alloway KD, Crist J, Mutic JJ, Roy SA (1999). Corticostriatal projections from rat barrel cortex have an anisotropic organization that correlates with vibrissal whisking behavior. J Neurosci 19: 10908–10922.
Andersen SL, Arvanitogiannis A, Pliakas AM, LeBlanc C, Carlezon WAJ (2002). Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci 5: 13–14.
Andersen SL, LeBlanc CJ, Lyss PJ (2001). Maturational increases in c-fos expression in the ascending dopamine systems. Synapse 41: 345–350.
Badiani A, Oates MM, Day HE, Watson SJ, Akil H, Robinson TE (1999). Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behav Brain Res 103: 203–209.
Basura GJ, Walker PD (1999). Differential sensitivity of tachykinin vs enkephalin gene expression in the posterior striatum in response to acute p-chloroamphetamine treatment during postnatal development. Dev Brain Res 112: 155–157.
Beckstead RM (1979). An autoradiographic examination of corticocortical and subcortical projections of the mediodorsal-projection (prefrontal) cortex in the rat. J Comp Neurol 184: 43–62.
Berendse HW, Galis-de Graaf Y, Groenewegen HJ (1992). Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J Comp Neurol 316: 314–347.
Berke JD, Hyman SE (2000). Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25: 515–532.
Bhat RV, Baraban JM (1993). Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. J Pharmacol Exp Ther 267: 496–505.
Bolanos CA, Barrot M, Berton O, Wallace-Black D, Nestler EJ (2003). Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 54: 1317–1329.
Brandon CL, Marinelli M, Baker LK, White FJ (2001). Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 25: 651–661.
Brandon CL, Steiner H (2003). Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum. Eur J Neurosci 18: 1584–1592.
Brog JS, Salyapongse A, Deutch AY, Zahm DS (1993). The patterns of afferent innervation of the core and shell in the ‘accumbens’ part of the rat ventral striatum: immunohistochemical detection of retrogradely transported fluoro-gold. J Comp Neurol 338: 255–278.
Brown LL, Sharp FR (1995). Metabolic mapping of rat striatum: somatotopic organization of sensorimotor activity. Brain Res 686: 207–222.
Brown LL, Smith DM, Goldbloom LM (1998). Organizing principles of cortical integration in the rat neostriatum: corticostriate map of the body surface is an ordered lattice of curved laminae and radial points. J Comp Neurol 392: 468–488.
Butcher SP, Liptrot J, Arbuthnott GW (1991). Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis. Neurosci Lett 122: 245–248.
Carelli RM, West MO (1991). Representation of the body by single neurons in the dorsolateral striatum of the awake, unrestrained rat. J Comp Neurol 309: 231–249.
Carlezon WAJ, Mague SD, Andersen SL (2003). Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 54: 1330–1337.
Cenci MA, Campbell K, Wictorin K, Björklund A (1992). Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia nigra in the rat. Eur J Neurosci 4: 376–380.
Chase TD, Brown RE, Carrey N, Wilkinson M (2003). Daily methylphenidate administration attenuates c-fos expression in the striatum of prepubertal rats. Neuroreport 14: 769–772.
Cowan RL, Wilson CJ (1994). Spontaneous firing patterns and axonal projections of single corticostriatal neurons in the rat medial agranular cortex. J Neurophysiol 71: 17–32.
Crawford CA, McDougall SA, Meier TL, Collins RL, Watson JB (1998). Repeated methylphenidate treatment induces behavioral sensitization and decreases protein kinase A and dopamine-stimulated adenylyl cyclase activity in the dorsal striatum. Psychopharmacology 136: 34–43.
Daunais JB, McGinty JF (1994). Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse 18: 35–45.
Donoghue JP, Herkenham M (1986). Neostriatal projections from individual cortical fields conform to histochemically distinct striatal compartments in the rat. Brain Res 365: 397–403.
Donoghue JP, Wise SP (1982). The motor cortex of the rat: cytoarchitecture and microstimulation mapping. J Comp Neurol 212: 76–88.
Drago J, Gerfen CR, Westphal H, Steiner H (1996). D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience 74: 813–823.
Ehrlich ME, Sommer J, Canas E, Unterwald EM (2002). Periadolescent mice show enhanced DeltaFosB upregulation in response to cocaine and amphetamine. J Neurosci 22: 9155–9199.
Gardier AM, Moratalla R, Cuellar B, Sacerdote M, Guibert B, Lebrec H et al (2000). Interaction between the serotoninergic and dopaminergic systems in D-fenfluramine-induced activation of c-fos and jun B genes in rat striatal neurons. J Neurochem 74: 1363–1373.
Gatley SJ, Pan D, Chen R, Chaturvedi G, Ding YS (1996). Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci 58: 231–239.
Gaytan O, al-Rahim S, Swann A, Dafny N (1997). Sensitization to locomotor effects of methylphenidate in the rat. Life Sci 61: PL101–107.
Gerasimov MR, Franceschi M, Volkow ND, Gifford A, Gatley SJ, Marsteller D et al (2000). Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. J Pharmacol Exp Ther 295: 51–57.
Gerfen CR, Wilson CJ (1996). The basal ganglia. In: Swanson LW, Björklund A, Hökfelt T (eds). Handbook of Chemical Neuroanatomy. Elsevier: Amsterdam. pp 371–468.
Gerfen CR, Young III WS (1988). Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 460: 161–167.
Graybiel AM (1990). Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13: 244–254.
Graybiel AM, Canales JJ, Capper-Loup C (2000). Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci 23: S71–S77.
Harlan RE, Garcia MM (1998). Drugs of abuse and immediate-early genes in the forebrain. Mol Neurobiol 16: 221–267.
Hoffer ZS, Alloway KD (2001). Organization of corticostriatal projections from the vibrissal representations in the primary motor and somatosensory cortical areas of rodents. J Comp Neurol 439: 87–103.
Hurd YL, Brown EE, Finlay JM, Fibiger HC, Gerfen CR (1992). Cocaine self-administration differentially alters mRNA expression of striatal peptides. Mol Brain Res 13: 165–170.
Hurd YL, Herkenham M (1992). Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Mol Brain Res 16: 97–104.
Hurd YL, Ungerstedt U (1989). In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur J Pharmacol 166: 251–260.
Hyman SE, Cole RL, Schwarzschild M, Cole D, Hope B, Konradi C (1996). Molecular mechanisms of striatal gene regulation: a critical role for glutamate in dopamine-mediated gene induction. In: Merchant KM (ed). Pharmacological Regulation of Gene Expression in the CNS. CRC Press: Boca Raton, FL. pp 115–131.
Hyman SE, Malenka RC (2001). Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2: 695–703.
Hyman SE, Nestler EJ (1996). Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 153: 151–162.
Izenwasser S, Coy AE, Ladenheim B, Loeloff RJ, Cadet JL, French D (1999). Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine. Eur J Pharmacol 373: 187–193.
Johansson B, Lindström K, Fredholm BB (1994). Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 59: 837–849.
Kankaanpaa A, Meririnne E, Seppala T (2002). 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat. Psychopharmacology 159: 341–350.
Keefe KA, Xochime C, Hanson GR, Adams DH (2002). Cocaine-induced predynorphin mRNA expression in the striatal matrix is dependent on serotonin. Soc Neurosci Abstr 28: 500.6.
Kincaid AE, Wilson CJ (1996). Corticostriatal innervation of the patch and matrix in the rat neostriatum. J Comp Neurol 374: 578–592.
Kollins SH, MacDonald EK, Rush CR (2001). Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol Biochem Behav 68: 611–627.
Kosofsky BE, Genova LM, Hyman SE (1995). Substance P phenotype defines specificity of c-fos induction by cocaine in developing rat striatum. J Comp Neurol 351: 41–50.
Kuczenski R, Segal DS (1997). Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 68: 2032–2037.
Lin JS, Hou Y, Jouvet M (1996). Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA 93: 14128–14133.
Martin-Iverson MT, Ortmann R, Fibiger HC (1985). Place preference conditioning with methylphenidate and nomifensine. Brain Res 332: 59–67.
Mathieu-Kia AM, Besson MJ (1998). Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat. Mol Brain Res 54: 141–151.
McDougall SA, Collins RL, Karper PE, Watson JB, Crawford CA (1999). Effects of repeated methylphenidate treatment in the young rat: sensitization of both locomotor activity and stereotyped sniffing. Exp Clin Psychopharmacol 7: 208–218.
McGeorge AJ, Faull RLM (1987). The organization and collateralization of corticostriate neurones in the motor and sensory cortex of the rat brain. Brain Res 423: 318–324.
McGeorge AJ, Faull RLM (1989). The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29: 503–537.
Meririnne E, Kankaanpaa A, Seppala T (2001). Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists. J Pharmacol Exp Ther 298: 539–550.
Mijnster MJ, Galis-de Graaf Y, Voorn P (1998). Serotonergic regulation of neuropeptide and glutamic acid decarboxylase mRNA levels in the rat striatum and globus pallidus: studies with fluoxetine and DOI. Mol Brain Res 54: 64–73.
Moll GH, Hause S, Ruther E, Rothenberger A, Huether G (2001). Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. J Child Adolesc Psychopharmacol 11: 15–24.
Morris BJ, Reimer S, Hollt V, Herz A (1988). Regulation of striatal prodynorphin mRNA levels by the raphe–striatal pathway. Brain Res 464: 15–22.
Nestler EJ (2001). Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119–128.
Papa M, Diewald L, Carey MP, Esposito FJ, Gironi Carnevale UA, Sadile AG (2002). A rostro-caudal dissociation in the dorsal and ventral striatum of the juvenile SHR suggests an anterior hypo- and a posterior hyperfunctioning mesocorticolimbic system. Behav Brain Res 130: 171–179.
Passingham RE, Myers C, Rawlins N, Lightfoot V, Fearn S (1988). Premotor cortex in the rat. Behav Neurosci 102: 101–109.
Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates. Academic Press: New York.
Penner MR, McFadyen MP, Pinaud R, Carrey N, Robertson HA, Brown RE (2002). Age-related distribution of c-fos expression in the striatum of CD-1 mice after acute methylphenidate administration. Dev Brain Res 135: 71–77.
Preuss TM (1995). Do rats have prefrontal cortex? The Rose–Woolsey–Akert program reconsidered. J Cogn Neurosci 7: 1–24.
Reep RL, Cheatwood JL, Corwin JV (2003). The associative striatum: organization of cortical projections to the dorsocentral striatum in rats. J Comp Neurol 467: 271–292.
Reep RL, Corwin JV (1999). Topographic organization of the striatal and thalamic connections of rat medial agranular cortex. Brain Res 841: 43–52.
Reep RL, Corwin JV, Hashimoto A, Watson RT (1987). Efferent connections of the rostral portion of medial agranular cortex in rats. Brain Res Bull 19: 203–221.
Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE (2002). Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. J Neurosci 22: 8705–8710.
Schenk S, Izenwasser S (2002). Pretreatment with methylphenidate sensitizes rats to the reinforcing effects of cocaine. Pharmacol Biochem Behav 72: 651–657.
Schweri MM, Skolnick P, Rafferty MF, Rice KC, Janowsky AJ, Paul SM (1985). [3H]Threo-(±)-methylphenidate binding to 3,4-dihydroxyphenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters. J Neurochem 45: 1062–1070.
Shuster L, Hudson J, Anton M, Righi D (1982). Sensitization of mice to methylphenidate. Psychopharmacology 77: 31–36.
Smith AJW, McGinty JF (1994). Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum. Mol Brain Res 21: 359–362.
Spangler R, Ho A, Zhou Y, Maggos CE, Yuferov V, Kreek MJ (1996). Regulation of kappa opioid receptor mRNA in the rat brain by ‘binge’ pattern cocaine administration and correlation with preprodynorphin mRNA. Mol Brain Res 38: 71–76.
Spangler R, Zhou Y, Maggos CE, Schlussman SD, Ho A, Kreek MJ (1997). Prodynorphin, proenkephalin and kappa opioid receptor mRNA responses to acute ‘binge’ cocaine. Mol Brain Res 44: 139–142.
Steiner H, Gerfen CR (1993). Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J Neurosci 13: 5066–5081.
Steiner H, Gerfen CR (1998). Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res 123: 60–76.
Steiner H, Gerfen CR (1999). Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons. Neuroscience 88: 795–810.
Steiner H, Kitai ST (2000). Regulation of rat cortex function by D1 dopamine receptors in the striatum. J Neurosci 20: 5449–5460.
Swanson JM, Volkow ND (2003). Serum and brain concentrations of methylphenidate: implications for use and abuse. Neurosci Biobehav Rev 27: 615–621.
Torres G, Horowitz JM (1999). Drugs of abuse and brain gene expression. Psychosom Med 61: 630–650.
Torres G, Rivier C (1994). Induction of c-fos in rat brain by acute cocaine and fenfluramine exposure: a comparison study. Brain Res 647: 1–9.
Trinh JV, Nehrenberg DL, Jacobsen JP, Caron MG, Wetsel WC (2003). Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice. Neuroscience 118: 297–310.
Uslaner J, Badiani A, Norton CS, Day HE, Watson SJ, Akil H et al (2001). Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur J Neurosci 13: 1977–1983.
Uylings HB, Groenewegen HJ, Kolb B (2003). Do rats have a prefrontal cortex? Behav Brain Res 146: 3–17.
Vargo JM, Marshall JF (1995). Time-dependent changes in dopamine agonist-induced striatal Fos immunoreactivity are related to sensory neglect and its recovery after unilateral prefrontal cortex injury. Synapse 20: 305–315.
Vargo JM, Marshall JF (1997). Reduced eticlopride-induced Fos expression in caudate-putamen and globus pallidus after unilateral frontal cortex injury: relation to neglect. Neuroscience 76: 1083–1095.
Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L et al (2001). Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 21(RC121): 1–5.
Walker PD, Capodilupo JG, Wolf WA, Carlock LR (1996). Preprotachykinin and preproenkephalin mRNA expression within striatal subregions in response to altered serotonin transmission. Brain Res 732: 25–35.
Wang JQ, McGinty JF (1996a). D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine. Synapse 22: 114–122.
Wang JQ, McGinty JF (1996b). Glutamatergic and cholinergic regulation of immediate-early gene and neuropeptide gene expression in the striatum. In: Merchant KM (ed). Pharmacological Regulation of Gene Expression in the CNS. CRC Press: Boca Raton, FL. pp 81–113.
Wang JQ, Smith AJW, McGinty JF (1995). A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin messenger RNA expression in rat forebrain. Neuroscience 68: 83–95.
Willuhn I, Sun W, Steiner H (2003). Topography of cocaine-induced gene regulation in the rat striatum: Relationship to cortical inputs and role of behavioural context. Eur J Neurosci 17: 1053–1066.
Wright AK, Norrie L, Ingham CA, Hutton EA, Arbuthnott GW (1999). Double anterograde tracing of outputs from adjacent ‘barrel columns’ of rat somatosensory cortex. Neostriatal projection patterns and terminal ultrastructure. Neuroscience 88: 119–133.
Wright AK, Ramanathan S, Arbuthnott GW (2001). Identification of the source of the bilateral projection system from cortex to somatosensory neostriatum and an exploration of its physiological actions. Neuroscience 103: 87–96.
Wright CI, Groenewegen HJ (1996). Patterns of overlap and segregation between insular cortical, intermediodorsal thalamic and basal amygdaloid afferents in the nucleus accumbens of the rat. Neuroscience 73: 359–373.
Yano M, Steiner H (2003). Temporal and regional topographies of methylphenidate-induced gene regulation in the striatum and cortex of the adult rat. Soc Neurosci Abstr 29: 855.17.
Yano M, Steiner H (2005). Methylphenidate (Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal circuits. Neuroscience, in press.
Acknowledgements
This work was supported by Grant DA11261 (HS) and an Individual National Research Service Award F30 DA017998 (MY) from the National Institute on Drug Abuse. We thank Joel Beverley for excellent technical assistance, and Dr Gloria Meredith for critical comments on the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yano, M., Steiner, H. Topography of Methylphenidate (Ritalin)-Induced Gene Regulation in the Striatum: Differential Effects on c-Fos, Substance P and Opioid Peptides. Neuropsychopharmacol 30, 901–915 (2005). https://doi.org/10.1038/sj.npp.1300613
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1300613
Keywords
This article is cited by
-
Fluoxetine Potentiates Oral Methylphenidate-Induced Gene Regulation in the Rat Striatum
Molecular Neurobiology (2021)
-
Distinct and simultaneously active plasticity mechanisms in mouse hippocampus during different phases of Morris water maze training
Brain Structure and Function (2015)
-
A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder
Psychopharmacology (2013)
-
Combinatorial topography and cell-type specific regulation of the ERK pathway by dopaminergic agonists in the mouse striatum
Brain Structure and Function (2013)
-
Attention-Deficit/Hyperactivity Disorder Genomics: Update for Clinicians
Current Psychiatry Reports (2012)
